Reyad, Raafat M.
Ghobrial, Hossam Z.
Shaker, Ehab H. https://orcid.org/0000-0002-6182-632X
Reyad, Ehab M.
Shaaban, Mohammed H.
Hashem, Rania H.
Darwish, Wael M.
Article History
Received: 17 May 2019
Accepted: 8 December 2019
First Online: 18 December 2019
Ethics approval and consent to participate
: The approval of the Institutional Review Board IRB office, National Cancer Institute, Fom EL Khalig, Cairo 11796,Egypt (approval No.: 201617013. 2P) was taken. The purpose, benefits, possible risks and expectations were explained to all patients before their enrollment in the study and a written informed consent was obtained from each patient.
: Not applicable.
: The authors declare that they have no competing interests.